Actavia Life Sciences, Inc. (RASP)

Actavia Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	0	0.07	0.04	0.01	0.01	0.05
Cash & Short-Term Investments	0	0.07	0.04	0.01	0.01	0.05
Cash Growth	-37.33%	90.50%	262.86%	-23.83%	-71.56%	17.27%
Prepaid Expenses	0.05	0.02	0.05	0.03	0.02	0.01
Other Current Assets	-	-	-	-	0	0.01
Total Current Assets	0.05	0.1	0.09	0.04	0.03	0.07
Property, Plant & Equipment	-	-	-	-	0	0
Goodwill	-	-	-	-	-	2.72
Other Intangible Assets	-	-	-	-	-	2.15
Total Assets	0.05	0.1	0.09	0.04	0.03	4.95
Accounts Payable	1.5	0.96	0.82	0.9	0.95	0.86
Accrued Expenses	0.42	0.88	0.72	1.18	1.23	1.28
Short-Term Debt	0.3	0.21	0.13	0.68	0.52	0.26
Other Current Liabilities	0	0	0.01	0.04	-	-
Total Current Liabilities	2.23	2.05	1.68	2.8	2.71	2.41
Long-Term Debt	-	-	0.09	-	-	-
Total Liabilities	2.23	2.05	1.77	2.8	2.71	2.41
Common Stock	0.77	0.77	0.18	0.07	0.07	0.07
Additional Paid-In Capital	25.95	25.94	22.35	20.71	19.91	19.78
Retained Earnings	-28.91	-28.66	-24.22	-23.53	-22.66	-17.31
Shareholders' Equity	-2.18	-1.96	-1.69	-2.75	-2.67	2.54
Total Liabilities & Equity	0.05	0.1	0.09	0.04	0.03	4.95
Total Debt	0.3	0.21	0.22	0.68	0.52	0.26
Net Cash (Debt)	-0.3	-0.14	-0.18	-0.67	-0.51	-0.21
Net Cash Per Share	-0.00	-0.00	-0.00	-0.01	-0.01	-0.00
Filing Date Shares Outstanding	771.81	771.81	771.81	179.98	68.91	68.91
Total Common Shares Outstanding	771.81	771.81	179.98	68.91	68.91	68.91
Working Capital	-2.18	-1.96	-1.6	-2.75	-2.68	-2.34
Book Value Per Share	-0.00	-0.00	-0.01	-0.04	-0.04	0.04
Tangible Book Value	-2.18	-1.96	-1.69	-2.75	-2.67	-2.34
Tangible Book Value Per Share	-0.00	-0.00	-0.01	-0.04	-0.04	-0.03

Updated May 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.